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Abstract
Polyethylenimine (PEI) and other polycations are good vehicles for transferring genes into the cells. In earlier reports, poly-L-lysine and
protamine have been shown to improve gene delivery with cationic liposomes. In this study, PEI, combined with different cationic liposomes,
was studied to determine the optimal conditions for gene delivery. The reporter genes, luciferase and green fluorescent protein, were used to
transfect human HeLa, HepG2 and hepatoma 2.2.15 cells with various combinations of PEIs (0.8 and 25 kDa), poly-L-lysine (15–30 kDa),
protamine and cationic liposomes. The highest expression level was achieved by using the combination of PEI 25 kDa (0.65 Ag/Ag of DNA,
nitrogen-to-DNA phosphate (N/P) ratio = 4.5) with 10 nmol of DOTAP–cholesterol (DOTAP–Chol, 1:1 w/w). This DNA complex
formulation dramatically increased the luciferase expression 10- to 100-fold, which was much higher than those of other polycations alone,
cationic liposomes alone or the combination. In addition, PEI/DOTAP–Chol combination had little cytotoxicity than DOTAP–Chol or other
cationic liposomes alone. The effect of oligonucleotide (ODN) delivery facilitated by PEI and cationic liposomes was also studied in the
hepatoma cell lines. We demonstrated an antisense ODN of p53 delivered by PEI/DOTAP–Chol combination effectively inhibited the
biosynthesis of p53 protein in HepG2 (68% inhibiton) and 2.2.15 cells (43% inhibition). Thus, the large PEI could synergistically increase the
transfection efficiency when combined with the cationic liposomes.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Liposomes and polycations are the two major classes of
nonviral gene delivery methods in vitro and in vivo [1–9].
Significant limitations of cationic liposomes are low trans-
fection efficiency and unable to transfect any cells, especially
the hepatoma cells. In order to solve the problems, the dis-
covery of new lipids and new helper compounds is currently
underway to improve the transfection efficiency of lipo-
somes. The addition of polycations, i.e. poly-L-lysine and
protamine, as co-polymer can markedly enhance the trans-
fection efficiency of several types of cationic liposome by 2–
28-fold in a number of cell lines in vitro [10] and in vivo [11].
Polyethylenimine (PEI) has different molecular weights
associated with different transfection efficiencies [8]. The
ability of DNA condensing properties and proton-sponge
effect of PEI are important factors for gene delivery [8,12],
whether genes may be delivered into cytoplasm via endo-
cytosis or targeted to the nucleus [13]. Only the PEIs larger
than 10 kDa have been used successfully in transfection
studies [8,14]. In them, the linear PEI of 22 kDa [15] and the
branched PEI of 25 kDa [16] are the most effective trans-
fection reagents used in vitro and in vivo.
Low-molecular-weight PEIs (average MW of 0.6 and 1.8
kDa) are ineffective in terms of gene transfer [17]. However,
if combined with cationic or anionic liposomes, such low-
molecular-weight PEIs can be effective to deliver the genes
into cells [18–22]. This effect may be due to the synergistic
advantages of both PEI and cationic liposomes. On the other
hand, the effectiveness of large PEI, such as 25 kDa, is
controversial as a good co-polymer in the combined use for
gene delivery [19,21,22].
We are interested in elucidating whether the combination
of PEIs and cationic liposomes enhances the transfection
efficiency in human cancer cells. We tested the different
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cationic liposomes and polycations in the combination
system for plasmid and oligonucleotide (ODN) delivery in
vitro, and aimed to optimize gene transfection condition.
2. Materials and methods
2.1. Materials
1,2-Dioleoyl-3-(trimethylammonium) propane (DOTAP),
dimethyl dioctadecyl ammonium bromide (DDAB), 1,2-
dioleoyl-3-sn-phosphatidyl-ethanolamine (DOPE) and cho-
lesterol were from Avanti Polar Lipids (Alabaster, AL,
USA). Polylysine (PLL) (15–30 kDa), protamine and PEIs
of different molecular weights (0.8 and 25 kDa) were
obtained from Aldrich-Sigma (St. Louis, MO, USA). Opti-
MEM I medium was from Gibco/BRL (Carlsbad, CA, USA).
Plasmid Maxiprep Kit was from Qiagen (Hilden, Germany).
Luciferase assay kit was purchased from Promega (Madison,
WI, USA). DC Protein Assay reagent was from Bio-Rad
(Hercules, CA, USA). The 18-mer phosphorothioated anti-
sense of p53 ODNs (246-CGGCTCCTCCATGGCAGT-
263) and sense (263-ACTGCCATGGAGGAGCCG-246)
were synthesized on a PE Applied Biosystems DNA synthe-
sizer. The sense ODNs of p53 were used as negative control.
Anti-p53 monoclonal antibodies were purchased from R&D
Systems (Minneapolis, MN, USA). Anti-h-actin and secon-
dary HRP-conjugated antibodies were from Aldrich-Sigma.
2.2. Cell cultures
Human HeLa, HepG2 and hepatoma 2.2.15 cells, which
are of hepatitis B virus (HBV) DNA transfected human
hepatocarcinoma cell line [23], were purchased from ATCC
(Maryland, USA). All cell lines were cultured in DMEMwith
high glucose (DMEM-HG) supplemented with 10% (v/v)
heat-inactivated fetal bovine serum. These cells were main-
tained at 37 jC, under 5%CO2. For transfection, 1105 cells
were initially seeded in 1 ml of medium in 12-well culture
plates and transfected at cell density of 70% confluency.
2.3. Plasmid preparations
pCMV-EGFP and pCMV-Luc, encoding the green fluo-
rescent protein and firefly luciferase, respectively, with
human cytomegalovirus promoter, were amplified in
DH5a strain of E. coli, and purified using the Qiagen
Plasmid Maxiprep Kit (Chatsworth, CA, USA).
Fig. 1. Effect of different PEIs on the transfection efficiency in HeLa cells. The cells were transfected with 1 Ag of pCMV-Luc plasmid complexed with PEI 0.8
or 25 kDa at ratios (w/w) from 0 to 3.65 (N/P ratio equivalent to 0–25) or with 10 nmol of DOTAP–Chol/DNA. The cells were incubated in the transfection
solution for 1 h and then in the growth medium for 24 h before the luciferase assay. These data are expressed as relative light unit (RLU) of luciferase activities
per milligram of total cell protein (meanF standard deviation, obtained from triplicate experiments). The experiment was repeated three times with similar
results.
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2.4. Liposome preparations
DOTAP, DDAB, DOPE and cholesterol were dissolved
in chloroform, sealed in ampoules filled with argon gas and
stored at  20 jC. Small unilamimellar vesicles (SUV)
were prepared by a combination of the standard thin-film
hydration method and repeated extrusion as described else-
where [24]. Briefly, cationic lipids with DOPE or choles-
terol (molar ratio 1:1) were dissolved in chloroform and
placed in a round-bottomed flask. The solvent was removed
by rotary evaporation under reduced pressure. The lipid film
was hydrated in 5% dextrose solution to give a final
concentration of 10 AM cationic lipids per milliliter. The
lipid solution was sequentially extruded through polycar-
bonate membranes, three times at pore size of 0.1 Am and
seven times at 0.05 Am by using high-pressure extrusion
equipment from Lipex Biomembranes (Vancouver, BC,
Canada) at 55 jC. The cationic liposomes were filter-
sterilized through Millex 0.22-Am-diameter filter and stored
at 4 jC in argon gas before use.
2.5. Preparations of nucleic acid/polycation/liposome
complexes
DNA of pCMV-Luc, pCMV-EGFP, sense or antisense
p53 ODNs were mixed with polycations (PLL, protamine
or PEI) of different weight ratios in 50 Al of HBS buffer (a
solution of 100 mM NaCl, 20 mM Hepes, pH 7.4).
Lipoplexes were prepared by gently mixing 10 nmol of
liposomes (based on the level of cationic lipids) in 50 Al of
HBS buffer with 1 Ag of ODNs, pCMV-Luc or pCMV-
EGFP plasmid in 50 Al of HBS buffer with or without
polycations. After incubation for 15 min at room temper-
ature, the DNA/polycation/liposome complexes were added
to the culture cells for transfection. Either luciferase activity
or GFP expression on these cells was examined (see
below).
2.6. Luciferase assay
Cells were seeded in the 12-well culture plates 1 day
before transfection. The culture medium was replaced with
0.9 ml of OPTI-MEM I medium before adding 0.1 ml of
DNA/polycation complex, DNA/liposome complex or
DNA/polycation/liposome complexes. After incubation for
1 h (in 5% CO2 at 37 jC), 1 ml of medium with 10% of
serum was added and incubated for another 24 h. On the day
of harvest, cells were washed with PBS twice and then lysed
with buffer containing 150 mM PBS, pH 7.4, 1% Triton X-
100, 1 mM dithiothreitol and 2 mM EDTA. Luciferase
activities in the lysates were evaluated by using the Mono-
light Luminometer 2010 from Becton-Dickinson (San Jose,
CA, USA). Protein content was measured by DC Protein
Assay kit with bovine serum albumin as standard. The data
Fig. 2. Effect of different polycations/DNA and DOTAP–Chol ratios on the
transfection efficiency in HeLa cells. The cells were transfected with 1 Ag
of pCMV-Luc plasmid with 10 nmol of DOTAP–Chol complexed with or
without 0–2 Ag of PLL (15–30 kDa), protamine and PEI 25 kDa. The cells
were incubated in the transfection solution for 1 h and then in the growth
medium for 24 h before the luciferase assay. These data are expressed as
relative light unit (RLU) of luciferase activities per milligram of total cell
protein (meanF standard deviation, obtained from triplicate experiments).
The experiment was performed three times with similar results.
Fig. 3. Effect of different cationic lipids on the transfection efficiency of
PEI/cationic liposomes combinations in HeLa cells. For the complex
formulation, 1 Ag of pCMV-Luc plasmid was mixed with 10 nmol of
different cationic liposomes indicated, in the presence or absence of 0.65 Ag
of PEI 25 kDa. The cells were incubated in the transfection solution for 1 h
and then in the growth medium for 24 h before the luciferase assay. These
data are expressed as relative light unit (RLU) of luciferase per milligram of
total cell protein (meanF standard deviation, obtained from triplicate
wells). The experiment was performed three times with similar results.
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were expressed as relative light unit (RLU) of luciferase per
milligram of total cellular protein. For the normalization, 1
ng of luciferase protein could generate 2000 RLU in our
luciferase activity assay.
2.7. Flow cytometry and fluorescent imaging analysis
The pictures of GFP-transfected cells were taken under
the fluorescent microscope after 24 to 48 h of incubation.
For flow cytometry, hepatoma cells after transfected with
pCMV-EGFP were washed with PBS and trypsinized.
Transfection efficiency was evaluated by scoring the per-
centage of cells expressing green fluorescence protein using
a FACS Calibur System from Becton-Dickinson. The
experiments were performed in triplicates and 10,000 cells
were count in each experiment.
2.8. Western blot analysis
Cells were lysed in a buffer composed of 150 mM NaCl,
50 mM Tris (pH 8.0), 5 mM EDTA, 1% (v/v) nonidet P-40,
1 mM phenylmethylsulfonyl fluoride, 20 Ag/ml aprotinin
and 25 Ag/ml leupeptin at 4 jC. Equal amounts of protein
extracts were resolved by SDS-polyacrylamide gel electro-
phoresis and transferred to a nitrocellulose filter. After
blocking with buffer containing 20 mM Tris–HCl (pH
7.5) and 150 mM NaCl, 5% nonfat milk for 1 h at room
temperature, the filter was incubated with specific anti-
bodies against p53 and h-actin for 1 h at room temperature
followed by the use of horseradish peroxidase-labeled
secondary antibodies. Blots were developed using a chem-
iluminescent detection system form Amersham Biosciences
UK Ltd. (Little Chalfont, Buckinghamshire, UK). Protein
bands on the film were quantified by scanning with Image-
Master densitometer from Amersham Pharmacia Biotech
(Piscataway, NJ, USA).
3. Results
3.1. Effect of different PEIs on gene delivery in HeLa cells
The transfection abilities of PEIs (MW 0.8 and 25 kDa)
and DOTAP–Chol were compared in this experiment. The
cells were transfected with 1 Ag of pCMV-Luc plasmid
complexed with PEI 0.8 or 25 kDa from 0 to 3.65 Ag (N/P
ratio equivalent to 0 to 25) or with 10 nmol of DOTAP–
Chol/DNA. When PEI/DNA weight ratioz 0.37, the trans-
fection efficiency of PEI 25 kDa was 1000-fold more
effective than that of PEI 0.8 kDa in the HeLa cells. The
Fig. 5. Effect on the transfection efficiency of polycation/DOTAP–Chol
combinations in liver cell lines. The human hepatoma HepG2 and 2.2.15
cells were transfected with 1 Ag of pCMV-Luc plasmid combined with the
choice of PEI 25 kDa (0.65 Ag), PLL (1.0 Ag) and protamine (0.8 Ag) before
adding DOTAP–Chol (10 nmol). The cells were incubated in the
transfection solution for 1 h and then in the growth medium for 24 h
before the luciferase assay. These data are expressed as relative light unit
(RLU) of luciferase activities per milligram of total cell protein (meanF
standard deviation, obtained from triplicate wells). Three independent
experiments were performed with similar results.
Fig. 4. Effect of different combinations of the transfection reagents in HeLa
cells. The transfection complexes were composed of 1 Ag of pCMV-Luc
plasmid with the choice of DOTAP–Chol (10 nmol) and PEI 25 kDa (0.65
Ag). The mixing procedures to form the DNA complexes were indicated in
the abscissa. HeLa cells were incubated in the transfection solution for 1 h
and then in the growth medium for 24 h before the luciferase assay. These
data are expressed as relative light unit (RLU) of luciferase activities per
milligram of total cell protein (meanF standard deviation, obtained from
triplicate wells) ( P< 0.001). The experiment was repeated three times with
similar results.
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Fig. 6. Effect of polycation/DOTAP–Chol combinations on the cell transfection. Human hepatoma HepG2 and 2.2.15 cells were transfected with 1 Ag of
pCMV-EGFP plasmid complexed with PLL, protamine or PEI 25 kDa at optimal weight ratio before adding 10 nmol of DOTAP–Chol. Cationic liposomes
such as Lipotectin and DOTAP–Chol served as control. The cells were incubated in the transfection solution for 1 h and then incubated in growth medium for
another 48 h. After incubation, the cells were washed with PBS and fixed with 4% paraformaldehyde for 15 min. Then the efficiency of transfected cells was
determined by fluorescence microscopy (a). For flow cytometry, hepatoma cells after transfection with pCMV-EGFP were washed, trypsinized and quantified
using the FACS machine as described in the Materials and methods (b).
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effectiveness of PEI 25 kDa was similar to DOTAP–Chol
complexes in this transfection experiment (Fig. 1).
3.2. The role of polycations in liposome-mediated gene
delivery in HeLa cells
The cells were transfected using PEI 25 kDa, PLL or
protamine combined with DNA and DOTAP–Chol. In the
presence of 10 nmol of DOTAP–Chol, the best luciferase
activity was achieved at a PEI/DNA weight ratio of 0.65,
PLL/DNA weight ratio of 1.0 and protamine/DNA weight
ratios of 0.8–2.0 (Fig. 2). The addition of polycations
irrespective of PEI, PLL or protamine to DOTAP–Chol
enhanced the transfection efficiency 10- to 100-fold. Addi-
tionally, we used the hemocytometer for the assessment of
cell toxicity. There was minimal cytotoxicity as cells were
treated with polycation/DOTAP–Chol combination (data
not shown).
3.3. The transfection efficiency of PEI on gene delivery was
combined with different cationic liposomes in HeLa cells
The different cationic liposomes were combined with
PEI 25 kDa for gene delivery in HeLa cells. DOTAP and
DDAB were individually formed liposomes with cholesterol
or DOPE as helper lipids. The highest expression level was
achieved by using the combination of PEI (0.65 Ag/Ag of
DNA, N/P ratio = 4.5) with 10 nmol of DOTAP–cholesterol
(DOTAP–Chol, 1:1 w/w) (Fig. 3).
3.4. Effect of different combinations with polycation- and
liposome-mediated gene transfection in HeLa cells
To determine the best mixing procedure to form the DNA
complexes, we added PEI 25 kDa and DOTAP–Chol to the
plasmid DNA in different orders. The best transfection
efficiency was achieved when PEI and DNA were mixed
first, and then added DOTAP–Chol (Fig. 4).
3.5. The use of polycations/DOTAP–cholesterol combina-
tion in the gene delivery to human hepatoma cells
In order to see whether the combination of DOTAP–
Chol and polycations can be used in other cells, we
performed our studies using hepatoma HepG2 and 2.2.15
cells. In the case of HeLa cells, the best formulation was
achieved with DNA/PEI/DOTAP–Chol at 1 Ag:0.65 Ag:10
nmol (Fig. 2). In adapting this combination to transfect
HepG2 and 2.2.15 cells, we found that it worked as good as
in HeLa cells and was 10 times better than Lipofectin in
both cell lines (Fig. 5).
3.6. Effect of the polycations/DOTAP–Chol combination on
the transfection of GFP reporter genes in human hepatoma
cells
The transfection efficiency was counted by green fluo-
rescence protein (GFP) expression in this experiment by
using combinations of polycations and cationic liposomes.
When DOTAP–Chol was added to the PEI/DNA com-
plexes, the number of green fluorescent cells increased,
compared with DNA/PLL/DOTAP–Chol, DNA/prot-
amine/DOTAP–Chol, Lipotectin and DOTAP–Chol alone
(Fig. 6a). These results showed that GFP expression was
maximized in hepatoma HepG2 and 2.2.15 cells at
DOTAP–Chol/DNA ratio (nmol/Ag) of 10 combined with
0.65 Ag of PEI 25 kDa. The percentage of green fluorescent-
positive cells was about 50% (hepatoma 2.2.15) and 40%
(HepG2) by FACS analysis. These expression levels were
10 times better than the use of DOTAP–Chol alone (Fig.
6b).
3.7. Use of PEI with DOTAP–cholesterol combination in
the delivery of antisense ODNs to hepatoma cells
In order to determine whether PEI 25 kDa and/or
DOTAP–Chol could deliver ODNs into cells, the p53
antisense ODNs were used as a surrogate. Hepatoma cells
were treated with PEI/DOTAP–Chol containing p53 anti-
sense ODN at a liposome/DNA ratio of 10. Both sense
ODN and antisense ODN alone had no effect in decreasing
the p53 protein production (Fig. 7). The inhibitory percent-
age of p53 protein expression in HepG2 cells was 68% as
using the PEI/DOTAP–Chol formulation. Similarly, p53
protein was also reduced 43% in the treated hepatoma
2.2.15 cells. As seen in these results, PEI combined with
DOTAP–Chol had a better delivery of ODN than DOTAP–
Chol alone.
Fig. 7. Western blot analysis of the inhibition of p53 protein expression by PEI/DOTAP–Chol combination. One microgram of sense or antisense ODN was
delivered into hepatoma HepG2 and 2.2.15 cells using 10 nmol of DOTAP–Chol with or without 0.65 Ag of PEI 25 kDa. DOTAP-Chol formulation is
indicated as DOC in this Figure, where as PEI 25 kDa/DOTAP-Chol formulation is indicated as LED25. h-actin was used as an equal loading indicator. The
experiment was performed four times with similar results. Protein bands on the film were quantified by scanning with ImageMaster densitometer. The p53
protein was normalized with h-actin in the same gel.
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4. Discussion
Nonviral DNA delivery is a multistage process involved
in DNA packaging, cell entry, endosomal escape, nuclear
localization and gene expression. These gene delivery
vehicles usually consist of cationic polymers (polycations)
or cationic liposomes. PEI is a synthetic polymer and has
various molecular weights with different efficiencies for
gene delivery [8]. The DNA condensing property and
proton-sponge effect are the characteristics of PEI as a
superior transfection reagent.
In this paper, a synergistic effect on the transfection
efficiency was clearly demonstrated by the combined use
of polycations and cationic liposomes. The highest expres-
sion level was achieved by using the combination of PEI 25
kDa (0.65 Ag/Ag of DNA, N/P ratio = 4.5) with 10 nmol of
DOTAP–Chol. This formulation dramatically increased the
luciferase or GFP expression 10- to 100-fold, which was
much higher than those of other polycations alone, cationic
liposomes alone or the combination. The optimal ratio of
PEI/DOTAP–Chol complexes that works well in HeLa cells
can be applied to liver cells, including hepatoma Huh7,
Hep3B (data not shown), HepG2 and 2.2.15 cells. Since a
complete condensation of DNA occurred at higher N/P ratio
[20], the synergism appeared when the plasmid DNA was
partially complexed but not fully condensed with PEI before
adding the DOTAP–Chol (Figs. 2 and 4). Furthermore, it
was proposed that DOPE promotes the endosomal mem-
brane fusion and allows the DNA release to the cytoplasm.
Therefore, DOPE is frequently formulated in the commer-
cially available transfection reagents. But from our long-
term experiences, the cationic liposomes containing choles-
terol, e.g. DOTAP–Chol, worked slightly better than the
one containing DOPE in the transfection of cultured cells.
The adding of PEI (N/P ratio less than 5) can further
enhance the cationic liposome-mediated gene delivery in
these experiments. It suggested that the conformation of
DNA complex, the proton-sponge effect and the membrane
fusion mechanism are important factors and synergistically
contributed to the gene transfection event [25,26].
Many polycations (PLL 4 kDa, PLL 20 kDa, PLL 200
kDa, PEI 25 kDa, PEI 800 kDa and dendrimer) and cationic
liposomes alone are not effective carriers for antisense ODN
[27,28]. In this study, we used the antisense ODN of p53 to
inhibit the p53 protein expression, as measured by immu-
noblotting with anti-p53 monoclonal antibodies [29]. A
significant decrease in p53 protein biosynthesis in HepG2
and hepatoma 2.2.15 cells was only seen with PEI/
DOTAP–Chol formulation but not with cationic liposomes
or PEI alone. In addition to the small PEIs [22,30], we used
the large-molecular-weight PEI to achieve the sufficient
transfection efficiency in this experiment. The nucleic acid
condensation by PEI/DOTAP–Chol could help the ODN
stably associated with the carriers, and would facilitate the
ODN release into the cytoplasm. To our knowledge, this
paper is the first one to describe the use of small amount of
PEI combined with cationic liposomes for the delivery of
plasmid DNA and ODNs to human cancer cells.
Moreover, we have found low toxicity in HeLa cells,
even at the high liposome/DNA ratio of 10 when combined
with PEI. The cell survival was at least 80%, which was
similar to the reports using PEI 50 and 800 kDa [31]. The
combination of PEI allowed us to use lower amount of
liposomes, which would be an advantage because excess
amount of cationic liposomes could cause cytotoxic effect.
In summary, the combination of PEI and DOTAP–Chol
caused more than 10-fold increases in the transfection
efficiency in many cells compared with using polymer or
liposome alone. A minimal toxicity was also shown to these
cultured cells in vitro. These data on PEI/DOTAP–Chol
delivery system suggested that this formulation is very
promising in delivering nucleic acids including plasmid
DNA, RNA and ODNs into cells. The further understanding
of the detail mechanism of the PEI/liposome-mediated
synergism is mandatory to improve the design of future
gene transfer tools.
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